  |
|
 ATP Publications [ View All ] 15-Deoxy-{delta}12, 14-prostaglandin J2 inhibits transcriptional ...[ read more ] Characterization of in vitro and in vivo metabolic pathways of th...[ read more ] ATP Resources Publications Kim HJ, Kim JY, Meng Z, Wang LH, Liu F, Conrads TP, Burke TR, Veenstra TD, Farrar WL. 15-Deoxy-{delta}12, 14-prostaglandin J2 inhibits transcriptional activity of estrogen receptor-{alpha} via covalent modification of DNA-binding domain.
Cancer Res 67: 2595-602, 2007. Lakhani NJ, Sparreboom A, Xu X, Veenstra TD, Venitz J, Dahut WL, Figg WD Characterization of in vitro and in vivo metabolic pathways of the investigational anticancer agent, 2-methoxyestradiol.
J Pharm Sci Jan 24, 2007. [Epub ahead of print]
Bowen C, Stuart A, Ju JH, Tuan J, Blonder J, Conrads TP, Veenstra TD, Gelmann EP NKX3.1 homeodomain protein binds to topoisomerase I and enhances its activity.
Cancer Res 67: 455-64, 2007 Ritt DA, Zhou M, Conrads TP, Veenstra TD, Copeland TD, Morrison DK. CK2 Is a component of the KSR1 scaffold complex that contributes to Raf kinase activation.
Curr Biol 17: 179-84, 2007. Xiao Z, Camalier CE, Nagashima K, Chan KC, Lucas DA, de la Cruz MJ, Gignac M, Lockett S, Issaq HJ, Veenstra TD, Conrads TP, Beck GR Jr. Analysis of the extracellular matrix vesicle proteome in mineralizing osteoblasts.
J Cell Physiol 210: 325-35, 2007. Lee S, Joshi A, Nagashima K, Freed EO, Hurley JH. Structural basis for viral late-domain binding to Alix.
Nat Struct Mol Biol 14: 194-9, 2007. Munshi UM, Kim J, Nagashima K, Hurley JH, Freed EO. An Alix fragment potently inhibits HIV-1 budding: Characterization of binding to retroviral YPXL late domains.
J Biol Chem 282: 3847-55, 2007. Xiao Z, Camalier CE, Nagashima K, Chan KC, Lucas DA, de la Cruz MJ, Gignac M, Lockett S, Issaq HJ, Veenstra TD, Conrads TP, Beck GR Jr. Analysis of the extracellular matrix vesicle proteome in mineralizing osteoblasts.
J Cell Physiol 210: 325-35, 2007 Varticovski L, Hollingshead MG, Robles AI, Wu X, Cherry J, Munroe DJ, Lukes L, Anver MR, Carter JP, Borgel SD, Stotler H, Bonomi CA, Nunez NP, Hursting SD,
Qiao W, Deng CX, Green JE, Hunter KW, Merlino G, Steeg PS, Wakefield LM, Barrett JC. Accelerated preclinical testing using transplanted tumors from genetically
engineered mouse breast cancer models.
Clin Cancer Res 13: 2168-77, 2007. Reinhold WC, Reimers MA, Maunakea AK, Kim S, Lababidi S, Scherf U, Shankavaram UT, Ziegler MS, Stewart C, Kouros-Mehr H, Cui H, Dolginow D, Scudiero DA,
Pommier YG, Munroe DJ, Feinberg AP, Weinstein JN. Detailed DNA methylation profiles of the E-cadherin promoter in the NCI-60 cancer cells.
Mol Cancer Ther 6: 391-403, 2007. Juretic N, Urzua U, Munroe DJ, Jaimovich E, Riveros N. Differential gene expression in skeletal muscle cells after membrane depolarization.
J Cell Physiol 210: 819-30, 2007. Liu F, Worthy KM, Bindu L, Giubellino A, Bottaro DP, Fisher RJ, Burke TR Jr. Utilization of achiral alkenyl amines for the preparation of high affinity Grb2
SH2 domain-binding macrocycles by ring-closing metathesis.
Org Biomol Chem 5: 367-72, 2007. Creighton-Gutteridge M, Cardellina JH 2nd, Stephen AG, Rapisarda A, Uranchimeg B, Hite K, Denny WA, Shoemaker RH, Melillo G. Cell type-specific, topoisomerase II-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation by NSC 644221.
Clin Cancer Res 13: 1010-8, 2007. Klarmann GJ, Eisenhauer BM, Zhang Y, Gotte M, Pata JD, Chatterjee DK, Hecht SM, Le Grice SF. Investigating the "steric gate" of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase by targeted insertion of unnatural amino acids.
Biochemistry 46: 2118-26, 2007. Baba M, Hong SB, Sharma N, Warren MB, Nickerson ML, Iwamatsu A, Esposito D, Gillette WK, Hopkins RF 3rd, Hartley JL, Furihata M, Oishi S, Zhen W, Burke TR Jr, Linehan WM, Schmidt LS, Zbar B. Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling.
Proc Natl Acad Sci U S A 103: 15552-7, 2006. Schmeisser H, Kontsek P, Esposito D, Gillette W, Schreiber G, Zoon KC. Binding characteristics of IFN-alpha subvariants to IFNAR2-EC and influence of the 6-histidine tag.
J Interferon Cytokine Res 12: 866-76, 2006. Susan Krueger, Joseph E. Curtis. Bradley Harris, Stephen Lockett, Steve C. Blacklow. Dudley K. Strickland, and Yun-Xing Wang, RAP Uses a Histidine Switch to Regulate Its Interaction with LRP in the ER and Golgi.
Molecular Cell, 22,3:423-30, 2006. Cho EH, Lockett SJ. Calibration and standardization of confocal microscopes.
Journal of Microscopy, 223,1:15-25, 2006. Luis G. Rodriguez, Stephen J. Lockett, and Gary R. Holtom Coherent Anti-Stokes Raman Scattering (CARS) Microscopy: A Biological Review.
Cytometry, 69A,8:779-791, 2006. Donghan Lee, Joseph D. Walsh, Irina Mikhailenko, Ping Yu, Molly Migliorini, Yibing Wu, Susan Krueger, Joseph E. Curtis. Bradley Harris, Stephen Lockett, Steve C. Blacklow. Dudley K. Strickland, and Yun-Xing Wang, RAP Uses a Histidine Switch to Regulate Its Interaction with LRP in the ER and Golgi.
Molecular Cell, 22,3:423-30, 2006. Cho EH, Lockett SJ. Calibration and standardization of confocal microscopes.
Journal of Microscopy, 223,1:15-25, 2006. Elizabeth Boeggeman, Boopathy Ramakrishnan, Charlton Kilgore, Nelly Khidekel, Linda C. Hsieh-Wilson, John T. Simpson, and Pradman K. Qasba, Direct Identification of Nonreducing GlcNAc Residues on N-Glycans of Glycoproteins Using a Novel Chemoenzymatic Method,
Bioconjugate Chem.; 2007; ASAP Web Release Date: 20-Mar-2007 Hsing AW, Zhang M, Rashid A, McGlynn KA, Wang BS, Niwa S, Ortiz-Conde BA, Goedert JJ, Fraumeni JF Jr, O'Brien TR, Gao YT. Hepatitis B and C virus infection and the risk of biliary tract cancer
Int J Cancer. 2008 Apr 15;122(8):1849-53. Welzel TM, Miley WJ, Parks TL, Goedert JJ, Whitby D, Ortiz-Conde BA. Real-time PCR assay for hepatitis B virus
J Clin Microbiol. 2006 Sep;44(9):3325-33. Tseng FC, O'Brien TR, Zhang M, Kral AH, Ortiz-Conde BA, Lorvick J, Busch MP, Edlin BR. Seroprevalence of hepatitis C virus and hepatitis B virus
Hepatology. 2007 Sep;46(3):666-71.
 |
|